DESCRIBE <http://purl.uniprot.org/SHA-384/087C7EEA9CBF3BE9EFD30DD4F8A0AD10A56C7C0F9E1C562817A2955BDDE9717552D5CDCBBE906B740E9BF60358854BB5>

Subject	Predicate	Object
http://purl.uniprot.org/SHA-384/087C7EEA9CBF3BE9EFD30DD4F8A0AD10A56C7C0F9E1C562817A2955BDDE9717552D5CDCBBE906B740E9BF60358854BB5	http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/087C7EEA9CBF3BE9EFD30DD4F8A0AD10A56C7C0F9E1C562817A2955BDDE9717552D5CDCBBE906B740E9BF60358854BB5	http://www.w3.org/2000/01/rdf-schema#comment	"The PARS2 gene produced a significant association signal in a recent replication study of all known CRS-associations and is now the first human gene to be re-sequenced within CRS research. PARS2 showed an accumulation of low-frequency variants in CRS patients compared to background populations."xsd:string
http://purl.uniprot.org/uniprot/#_3B420767C59933182CE3ECDC1A808E9AF6A4754A81A7D0EEC8BD843368BDF6EBB22FF8D9BDBD7474AD84BFB686790B04	http://www.w3.org/1999/02/22-rdf-syntax-ns#subject	http://purl.uniprot.org/SHA-384/087C7EEA9CBF3BE9EFD30DD4F8A0AD10A56C7C0F9E1C562817A2955BDDE9717552D5CDCBBE906B740E9BF60358854BB5
http://purl.uniprot.org/uniprot/Q7L3T8	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/087C7EEA9CBF3BE9EFD30DD4F8A0AD10A56C7C0F9E1C562817A2955BDDE9717552D5CDCBBE906B740E9BF60358854BB5
http://purl.uniprot.org/uniprot/#_Q7L3T8-mappedCitation-27348859	http://purl.uniprot.org/core/mappedAnnotation	http://purl.uniprot.org/SHA-384/087C7EEA9CBF3BE9EFD30DD4F8A0AD10A56C7C0F9E1C562817A2955BDDE9717552D5CDCBBE906B740E9BF60358854BB5